US 11395838
Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome
granted A61KA61K2035/115A61K31/215
Quick answer
US patent 11395838 (Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome) held by The Board of Regents of the University of Texas System expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jul 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2035/115, A61K31/215, A61K35/04, A61K35/17